Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers

American Heart Journal

Volumn 160, Issue 3, 2010, Pages 458-463

  Asthana, Asha ^a   Johnson, Heather M ^a   Piper, Megan E ^a   Fiore, Michael C ^a   Baker, Timothy B ^a   Stein, James H ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBON MONOXIDE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINE; NICOTINE PATCH; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; EDUCATIONAL STATUS; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; LOZENGE; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; MIDDLE AGED; PROCEDURES; SMOKING;

ADULT; C-REACTIVE PROTEIN; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION;

EID: 77956361749     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.06.006     Document Type: Article

References (28)

1. Yusuf S., Hawken S., and Ounpuu S. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
2. Doll R., Peto R., and Boreham J. Mortality in relation to smoking: 50 years' observations on male British doctors BMJ 328 2004 1519
3. Freund K.M., Belanger A.J., and D'Agostino R.B. The health risks of smoking. The Framingham Study: 34 years of follow-up Ann Epidemiol 3 1993 417 424
4. Rosenberg L., Kaufman D.W., and Helmrich S.P. The risk of myocardial infarction after quitting smoking in men under 55 years of age N Engl J Med 313 1985 1511 1514
5. Rosenberg L., Palmer J.R., and Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking N Engl J Med 322 1990 213 217
6. J.M. Johnson, L. Gossett, and M.E. Piper Effects of smoking and smoking cessation on endothelial function: one-year outcomes from a randomized clinical trial J Am Coll Cardiol 55 2010 [in press]
7. Yasue H., Hirai N., and Mizuno Y. Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers Circ J 70 2006 8 13
8. Pearson T.A., Mensah G.A., and Alexander R.W. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
9. Hansen L.K., Grimm Jr.R.H., and Neaton J.D. The relationship of white blood cell count to other cardiovascular risk factors Int J Epidemiol 19 1990 881 888
10. Danesh J., Collins R., and Appleby P. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 279 1998 1477 1482
11. Miller M., Zhan M., and Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey Arch Intern Med 165 2005 2063 2068
12. Hastie C.E., Haw S., and Pell J.P. Impact of smoking cessation and lifetime exposure on C-reactive protein Nicotine Tob Res 10 2008 637 642
13. Bazzano L.A., He J., and Muntner P. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States Ann Intern Med 138 2003 891 897
14. Ohsawa M., Okayama A., and Nakamura M. CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers Prev Med 41 2005 651 656
15. Wannamethee S.G., Lowe G.D., and Shaper A.G. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease Eur Heart J 26 2005 1765 1773
16. Rohde L.E., Hennekens C.H., and Ridker P.M. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men Am J Cardiol 84 1999 1018 1022
17. Gossett L.K., Johnson H.M., and Piper M.E. Smoking Intensity and Lipoprotein Abnormalities in Active Smokers J Clin Lipidol 3 2009 372 378
18. Piper M.E., Smith S.S., and Schlam T.R. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies Arch Gen Psychiatry 66 2009 1253 1262
19. Craig C.L., Marshall A.L., and Sjostrom M. International physical activity questionnaire: 12-country reliability and validity Med Sci Sports Exerc 35 2003 1381 1395
20. Heatherton T.F., Kozlowski L.T., and Frecker R.C. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire Br J Addict 86 1991 1119 1127
21. Murray R.P., Connett J.E., and Istvan J.A. Relations of cotinine and carbon monoxide to self-reported smoking in a cohort of smokers and ex-smokers followed over 5 years Nicotine Tob Res 4 2002 287 294
22. Velicer W.F., Prochaska J.O., and Rossi J.S. Assessing outcome in smoking cessation studies Psychol Bull 111 1992 23 41
23. Bermudez E.A., Rifai N., and Buring J.E. Relation between markers of systemic vascular inflammation and smoking in women Am J Cardiol 89 2002 1117 1119
24. Gonzales D., Rennard S.I., and Nides M. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial JAMA 296 2006 47 55
25. Jorenby D.E., Hays J.T., and Rigotti N.A. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 296 2006 56 63
26. Cohen B.E., Panguluri P., and Na B. Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the Heart and Soul Study Psychiatry Res 175 2010 133 137
27. Govil S.R., Weidner G., and Merritt-Worden T. Socioeconomic status and improvements in lifestyle, coronary risk factors, and quality of life: the Multisite Cardiac Lifestyle Intervention Program Am J Public Health 99 2009 1263 1270
28. Yarnell J., Yu S., and McCrum E. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study Int J Epidemiol 34 2005 268 275